Logo
x

Search

Subscribe Now

Covid-19 vaccine

GSK and SK Bioscience Initiate P-III Study of GBP510 Against AZ/Oxford's COVID-19 Vaccine

GSK and SK Bioscience Initiate P-III Study of GBP510 Against AZ/Oxford's COVID-19 Vaccine

  • August 31, 2021
Pfizer and BioNTech's Comirnaty Receive the US FDA's Approval to Prevent COVID-19 in Individuals Aged 16 Years and Older

Pfizer and BioNTech's Comirnaty Receive the US FDA's Approval to Prevent COVID-19 in Individuals Aged 16 Years and Older

  • August 24, 2021
Novavax's COVID-19 Vaccine Demonstrates 90.4% Efficacy in P-III PREVENT-19 Study

Novavax's COVID-19 Vaccine Demonstrates 90.4% Efficacy in P-III PREVENT-19 Study

  • June 15, 2021
Pfizer and BioNTech Receive EC's Conditional Marketing Approval for the COVID-19 Vaccine in Adolescents

Pfizer and BioNTech Receive EC's Conditional Marketing Approval for the COVID-19 Vaccine in Adolescents

  • May 31, 2021
Sanofi and GSK Initiate P-III Clinical Study of their COVID-19 Vaccine

Sanofi and GSK Initiate P-III Clinical Study of their COVID-19 Vaccine

  • May 27, 2021
Pfizer Initiates Study to Evaluate its Pneumococcal Vaccine with Booster dose of its COVID-19 Vaccine

Pfizer Initiates Study to Evaluate its Pneumococcal Vaccine with Booster dose of its COVID-19 Vaccine

  • May 24, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.